Frankfurt - Delayed Quote USD
Traws Pharma, Inc. (0T20.F)
0.0000
-6.6000
(-100.00%)
As of September 23 at 8:16:48 AM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
24,962
22,683
39,372
55,478
Total Liabilities Net Minority Interest
56,592
12,011
11,063
9,358
Total Equity Gross Minority Interest
-31,630
10,672
28,309
46,120
Total Capitalization
-31,630
10,672
28,309
46,120
Common Stock Equity
-31,630
10,672
28,309
46,120
Net Tangible Assets
-31,630
10,672
28,309
46,120
Working Capital
13,418
13,440
31,301
49,315
Invested Capital
-31,630
10,672
28,309
46,120
Tangible Book Value
-31,630
10,672
28,309
46,120
Share Issued
3,633.7510
840.1360
837.0390
835.8220
Ordinary Shares Number
3,633.7510
840.1360
837.0390
835.8220
12/31/2021 - 8/29/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
5IU.F Isofol Medical AB (publ)
0.1551
-1.71%
6DW.F D. Western Therapeutics Institute, Inc.
0.5450
0.00%
2KZ0.F Kezar Life Sciences, Inc.
4.1200
+5.64%
3EE0.F Kancera AB (publ)
0.0869
-11.33%
2X10.DU Abivax SA
5.95
+2.59%
BTTAY Biotest Aktiengesellschaft
24.23
0.00%
B1Q.F NRX Pharmaceuticals Inc. R
1.6100
+1.26%
0RU9.IL 0RU9.IL,0P0000KJ6A,0
1,147,190.00
0.00%
5LH0.F Guard Therapeutics International AB (publ)
1.0800
+4.85%
6JU0.F BioCardia, Inc.
0.0000
-100.00%